In the increasingly complex medical world, Diabeta is establishing itself as an innovative medical chatbot, providing essential virtual support for healthcare professionals. This lightweight tool is distinguished by its ability to provide up-to-date and comprehensive information on diabetes drawn from official medical sources such as Summaries of Product Characteristics (SmPCs), protocols and official therapeutic guidelines.
DIABETES: A VERSATILE TOOL FOR HEALTH PROFESSIONALS
One of the distinguishing aspects of Diabeta is its versatility, being adapted for use in various medical spectrums. This chatbot processes information from trusted medical sources, thus providing high-quality support for specialists in different fields.
ANALYSIS OF USE IN MEDICAL PRACTICE
According to a recent analysis, Diabeta has captured the attention and trust of healthcare professionals, being significantly used by various categories of specialists. Here are the percentages of use for different categories of doctors:
- Primary Physicians: 38.9%
- Resident doctors: 23.3%
- Specialty doctors: 37.8%
These figures indicate that Diabeta is becoming an essential tool in the arsenal of resources of doctors from different specialties, giving them quick access to up-to-date and reliable information for managing patients with diabetes.
FACILITATING REAL-TIME DECISION-MAKING
By extracting information from official medical sources, Diabeta not only supports health professionals, but also facilitates real-time decision making. The chatbot thus becomes a reliable partner for doctors, helping them find up-to-date, accurate and relevant information to the questions asked.
Diabeta not only simplifies doctors’ work, but also redefines how they access and apply vital medical information. Through its commitment to excellence and relevance, Diabeta becomes a reliable ally in medical efforts to provide the best care for patients.
Developed by the Romanian company Apollo Technologies, DIABETA benefits from the support of prestigious partners such as Novo Nordisk, Boehringer Ingelheim and Medtronic. This partnership shows how a local initiative can have a global impact, bringing together resources and experiences to tackle diabetes challenges.
